Stocks
Contact us
Enavate Sciences · Menlo Park, United States

Enavate Sciences

$300M$300M roundStartup profile

Fundamentalsi

Latest valuationNot disclosed
Credibility rating5/5
Revenue / run rateNot disclosed
StageStartup profile
Latest roundPrivate Equity · $300M
Total funding$300M
Team sizeTeam size not disclosed
LocationMenlo Park, United States
IndustryStartup
Source records1

Ownership data

Cap table not disclosed

Enavate Sciences does not include shareholding history in the normalized startup source files.

Financial performance

All Financials
Source snapshot
REVENUE (USD)Not disclosed Not disclosed
FUNDING (USD)$300M Private Equity · $300M
Insufficient history

Historical revenue and profit series are not present in the source files for this private company.

REVENUE GROWTHVALUE

1Y (TTM)Not disclosed

3Y CAGRNot disclosed

PROFIT GROWTHVALUE

1Y (TTM)Not disclosed

3Y CAGRNot disclosed

About

Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need. Through the application of capital support and operational experience, Enavate strives to enable and empower a diverse portfolio of therapeutics companies to accelerate innovation. To learn more about Enavate, please visit www.enavatesciences.com.

This profile is normalized from the startup source files. Exact historical financials are shown only when present in the dataset.

CEO/MDNot disclosedFounded in2022StatusStartup profile
Source metrics Explore dashboard

Sources

Employbl recent Bay Area fundingcompany, website, hq_city, year_founded, latest_round, latest_round_amount, total_investment, description

Angel Investors and Venture Capital (1)

InvestorTypeSignal
Founder / employee ownershipBootstrappedNot disclosed in source records

Similar companies

See more
CompanyStartup metricSignal rangeValuationCategory
Altos LabsAL$3B$3B roundLHNot disclosedValuationStartupStartupSandboxAQSANDBOXA$500M$500M roundLHNot disclosedValuationStartupStartupNightpeak EnergyNE$200M$200M roundLHNot disclosedValuationStartupStartupApogee TherapeuticsAT$169M$149M roundLHNot disclosedValuationStartupStartup